Endoscopy 2014; 46(S 01): E427-E428
DOI: 10.1055/s-0034-1377433
Cases and Techniques Library (CTL)
© Georg Thieme Verlag KG Stuttgart · New York

Postgastrectomy protein-losing cytomegalovirus jejunitis in an immunocompromised patient

Philip Roelandt
1   Gastroenterology Department, University Hospitals Leuven, Leuven, Belgium
,
Helene Poels
1   Gastroenterology Department, University Hospitals Leuven, Leuven, Belgium
,
Ester Meeus
2   Pathology Department, University Hospitals Leuven, Leuven, Belgium
,
Eric Van Cutsem
3   Digestive Oncology Department, University Hospitals Leuven, Leuven, Belgium
,
Hans Prenen
3   Digestive Oncology Department, University Hospitals Leuven, Leuven, Belgium
› Author Affiliations
Further Information

Publication History

Publication Date:
14 October 2014 (online)

Preview

A 59-year-old man was admitted because of nausea and fatigue. He had been diagnosed with gastric adenocarcinoma 7 months earlier, and because of gastric outlet obstruction had undergone total gastrectomy with esophagojejunostomy and omentectomy (pT3N3bM0R1). Postoperatively, platinum-based chemotherapy was initiated, followed by radiochemotherapy (5-fluorouracil + 45 Gy) approximately 2 weeks before admission.

Initially, the nausea and fatigue were attributed to ongoing radiochemotherapy. During admission the patient became bedbound, with pronounced anasarca edema secondary to severe hypoalbuminemia (lowest level 9.9 g/L, normal 35 – 52 g/L) despite maximal supportive care, suggestive of protein-losing enteropathy (proteinuria was only mild). From the esophagojejunostomy onwards, the mucosa was severely inflamed with ulcerations, desquamation, and spontaneous submucosal hemorrhages for approximately 15 cm in the jejunum ([Fig. 1 a, b]). Microscopic examination revealed extensive ulceration with granulation and dense infiltration of mononuclear cells, cytomegaly, and Cowdry inclusions ([Fig. 1 c]). The diagnosis of cytomegalovirus (CMV) jejunitis was strengthened by positive serum CMV polymerase chain reaction (PCR; 3.84 log copies/mL). After 2 weeks of treatment with ganciclovir, the patient’s general condition recovered and CMV PCR became negative. At 1 month after discharge, the patient was in good general condition with an albumin level of 31.2 g/L ([Fig. 1 d]).

Fig. 1 Cytomegalovirus jejunitis in an immunocompromised patient. a, b Upper gastrointestinal endoscopy revealed inflamed mucosa from the esophagojejunostomy, followed by ulcerative jejunitis with spontaneous submucosal hemorrhages. c Hematoxylin and eosin staining showed cytomegaly (arrow heads) and Cowdry inclusion body (arrow), with specific cytomegalovirus staining positive (insert). d Serum albumin levels over time. Green bar indicates treatment period with ganciclovir.

Zoom
Zoom
Zoom
Zoom

Although CMV infection is mostly asymptomatic or gives rise to only mild mononucleosis-like symptoms, in immunocompromised or critically ill patients it can cause life-threatening complications [1] [2] [3]. CMV enteritis occurs in only 4 % of patients with CMV disease and is mostly restricted to a defined area rather than being panenteric [4]. As shown in inflammatory bowel diseases where CMV infects areas of already inflamed mucosa [5], it is likely that mucosal changes secondary to radiotherapy provide favorable conditions for CMV infection. The protein-losing enteropathy was most likely a combination of inflammatory exudation and villous atrophy with increased permeability associated with CMV infection [6].

This case illustrates that CMV should be included in the differential diagnosis of protein-losing enteropathy, especially following radiation therapy, and that biopsies should be taken to investigate CMV even when other potential explanations of mucositis are present.

Endoscopy_UCTN_Code_CCL_1AC_2AH